The Glioblastoma Therapeutics Network (GTN; U19 Clinical Trial Required) is a funding opportunity from the National Institutes of Health aimed at supporting clinical trial research focused on glioblastoma therapeutics. Specific details on eligibility and application requirements are not provided in the listing.
Eligibility details not specified in the grant listing. Contact the funding organization for requirements.
